BlackRock Institutional Trust’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$1.74M Buy
6,429
+16
+0.2% +$4.32K ﹤0.01% 3103
2016
Q3
$2.54M Buy
6,413
+149
+2% +$59K ﹤0.01% 2955
2016
Q2
$2.17M Buy
6,264
+485
+8% +$168K ﹤0.01% 2998
2016
Q1
$4.81M Sell
5,779
-51
-0.9% -$42.4K ﹤0.01% 2680
2015
Q4
$6.1M Buy
5,830
+158
+3% +$165K ﹤0.01% 2602
2015
Q3
$4.45M Buy
5,672
+653
+13% +$512K ﹤0.01% 2777
2015
Q2
$6.6M Buy
5,019
+962
+24% +$1.27M ﹤0.01% 2639
2015
Q1
$8.25M Buy
4,057
+1,398
+53% +$2.84M ﹤0.01% 2512
2014
Q4
$5.12M Buy
2,659
+1,706
+179% +$3.28M ﹤0.01% 2720
2014
Q3
$781K Sell
953
-413
-30% -$338K ﹤0.01% 3386
2014
Q2
$1.32M Buy
1,366
+228
+20% +$220K ﹤0.01% 3337
2014
Q1
$1.23M Sell
1,138
-893
-44% -$967K ﹤0.01% 3338
2013
Q4
$1.8M Buy
2,031
+297
+17% +$263K ﹤0.01% 3206
2013
Q3
$1.96M Buy
1,734
+173
+11% +$196K ﹤0.01% 3140
2013
Q2
$1.84M Buy
+1,561
New +$1.84M ﹤0.01% 3120